Al-Dawaa secures second distributor in UAE and Qatar
The Saudi pharmaceutical company announced that it has signed an agreement with Saqala Medical to designate it as a second distributor for its products in the UAE and Qatar for a period of five years, with the possibility of a two-year extension. This move aims to enhance the distribution network, improve supply chain efficiency, and ensure product availability in both markets. No immediate financial impact is expected upon signing the contract, as revenue will depend on sales volume and orders during the period.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)